From: Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction
 | Visit | Chitosan (mean ± SD) [range] | Placebo (mean ± SD) [range] | P value between groups |
---|---|---|---|---|
Body mass index(Kg/m2) | Day 45 (n = 59, 31) | -0.69 ± 0.53@ [-2.15 – 0.32] | -0.11 ± 0.50 [-1.19 – 1.01] | < 0.0001 |
Day 90 (n = 56, 30) | -1.20 ± 0.76@ [-3.65 – 0.73] | -0.11 ± 0.59 [-1.81 – 1.14] | < 0.0001 | |
Body fat (%) | Day 45 (n = 59, 31) | -0.38 ± 1.17@ [-6.60 – 2.80] | -0.11 ± 1.12 [-3.70 – 2.80] | 0.034 |
Day 90 (n = 56, 30) | -0.98 ± 1.27@ [-6.80 – 2.60] | -0.05 ± 0.98 [-2.70 – 2.30] | < 0.0001 | |
Visceral fat (%) | Day 45 (n = 59, 31) | -0.38 ± 0.71 [-3.0 – 1.0] | -0.19 ± 0.54 [-2.0 – 1.0] | 0.127 |
Day 90 (n = 56, 30) | -1.28 ± 1.12@ [-4.0 – 1.0] | -0.43 ± 0.85 [-2.0 – 2.0] | 0.001 | |
Muscle mass (Kg) | Day 45 (n = 59, 31) | -0.48 ± 1.51 [-11.10 – 1.20] | -0.20 ± 0.89 [-2.50 – 2.70] | 0.253 |
Day 90 (n = 56, 30) | −0.74 ± 1.57@ [−11.50 – 1.20] | -0.08 ± 1.16 [-3.20 – 3.10] | 0.0008 | |
Upper abdominal circumference (cm) | Day 45 (n = 59, 31) | -0.92 ± 1.25@ [-6.0 – 2.0] | -0.35 ± 0.95 [-3.0 – 1.0] | 0.020 |
Day 90 (n = 56, 30) | -2.17 ± 1.98@ [-8.0 – 2.0] | -0.50 ± 1.10 [-3.0 – 1.0] | < 0.0001 | |
Hip circumference (cm) | Day 45 (n = 59, 31) | -1.05 ± 1.05@ [-4.0 – 0.0] | -0.41 ± 1.14 [-4.0 – 2.0] | 0.0024 |
Day 90 (n = 57, 30) | -2.07 ± 1.51@ [-6.0 – 2.0] | -0.66 ± 1.24 [-3.0 – 2.0] | < 0.0001 | |
Waist circumference (cm) | Day 45 (n = 59, 31) | -0.91 ± 1.68@ [-8.00 – 6.00] | -0.64 ± 1.22 [-1.00 – 6.00] | 0.027 |
Day 90 (n = 57, 30) | -1.97 ± 2.20@ [-8.00 – 7.00] | -0.90 ± 1.47 [-1.00 – 7.00] | < 0.0001 | |
Waist to hip ratio | Day 45 (n = 59, 31) | -0.0027 ± 0.02 [-0.13 – 0.04] | -0.0035 ± 0.01 [-0.03 – 0.03] | 0.091 |
Day 90 (n = 57, 30) | -0.0010 ± 0.02 [-0.13 – 0.07] | -0.0033 ± 0.01 [-0.02 – 0.04] | 0.768 |